U.S. Brand Names:
Skelaxin®
Generic Available:
No
Canadian Brand Names:
Skelaxin®
Use:
Relief of discomfort associated with acute, painful musculoskeletal conditions
Pregnancy Risk Factor:
C
Contraindications:
Hypersensitivity to metaxalone or any component of the formulation; impaired hepatic or renal function, history of drug-induced hemolytic anemias or other anemias
Warnings/Precautions:
Use with caution in patients with impaired hepatic function
Adverse Reactions:
Frequency not defined.
Central nervous system: Paradoxical stimulation, headache, drowsiness, dizziness, irritability
Dermatologic: Allergic dermatitis
Gastrointestinal: Nausea, vomiting, stomach cramps
Hematologic: Leukopenia, hemolytic anemia
Hepatic: Hepatotoxicity
Miscellaneous: Anaphylaxis
Overdosage/Toxicology:
Signs and symptoms: No major toxicities have been reported
Drug Interactions:
Increased effect of alcohol, CNS depressants
Ethanol/Nutrition/Herb Interactions:
Ethanol: Avoid ethanol (may increase CNS depression).
Mechanism of Action:
Does not have a direct effect on skeletal muscle; most of its therapeutic effect comes from actions on the central nervous system
Pharmacodynamics/Kinetics:
Onset of action: ~1 hour
Duration: ~4-6 hours
Metabolism: Hepatic
Bioavailability: Not established; food may increase
Half-life elimination: 9 hours
Time to peak: Tmax: 3 hours
Excretion: Urine (as metabolites)
Dosage:
Children >12 years and Adults: Oral: 800 mg 3-4 times/day
Administration:
May be administered with or without food. However, serum concentrations may be increased when administered with food; clinical significance has not been established. Patients should be monitored.
Test Interactions:
False-positive Benedict's test
Dietary Considerations:
Administration with food may increase serum concentrations.
Patient Education:
Avoid alcohol and other CNS depressants; may cause drowsiness, impairment of judgment, or coordination; notify physician of dark urine, pale stools, yellowing of eyes, severe nausea, vomiting, or abdominal pain
Dental Health: Effects on Dental Treatment:
No significant effects or complications reported
Dental Health: Vasoconstrictor/Local Anesthetic Precautions:
No information available to require special precautions
Mental Health: Effects on Mental Status:
Drowsiness and dizziness are common; may cause paradoxical stimulation
Mental Health: Effects on Psychiatric Treatment:
May cause leukopenia; use caution with clozapine and carbamazepine; concurrent use with psychotropics may produce additive sedation
Dosage Forms:
[DSC] = Discontinued product
Tablet: 400 mg [DSC], 800 mg
International Brand Names:
Skelaxin® (CA)